The NHS in England has announced that 17 and 18-year-old students preparing for university can now book meningococcal B (MenB) vaccinations at community pharmacies nationwide, a move designed to increase uptake of protection against a potentially fatal bacterial infection. The vaccination programme, now accessible via high street pharmacies, aims to reach hundreds of thousands of young people before the autumn term begins.
Key takeaways
- MenB vaccination appointments are now bookable at high street pharmacies across England for 17 and 18-year-olds
- The NHS expansion addresses meningococcal disease risk, which remains a leading cause of bacterial meningitis in adolescents and young adults
- Community pharmacy access is expected to increase vaccination coverage among university-bound students before term starts
Strong Evidence
Addressing a preventable risk
Meningococcal disease caused by serogroup B remains a significant health threat for adolescents and young adults, particularly in congregate settings such as university halls of residence. According to NHS England, the MenB vaccine has been part of the routine immunisation schedule for infants since 2015, but catch-up vaccination for older teenagers was previously limited to GP-based services. By extending access to high street pharmacies, the health service aims to reduce barriers to vaccination and protect a vulnerable population cohort entering high-risk environments.
Pharmacy-based delivery improves access
Community pharmacies represent a widely distributed healthcare resource, with thousands of locations across England. The NHS decision to enable pharmacists to administer MenB vaccinations reflects evidence that pharmacy-based immunisation programmes can improve uptake by reducing appointment wait times and geographical barriers. Students can now book appointments at their local pharmacy without requiring a GP referral, streamlining the vaccination pathway during a busy period of university preparation.
Meningococcal B Disease: Risk by Age and Setting
Peak incidence in adolescents and young adults, particularly in congregate environments. United Kingdom epidemiology.
Source: NHS England, 2026 | Georgian Medical Journal News
Hundreds of thousands of 17 and 18-year-old students across England can now access MenB vaccination at high street pharmacies, eliminating traditional GP-based appointment constraints.
— NHS England Immunisation Programme (2026)
Clinical rationale and vaccine effectiveness
The MenB vaccine protects against meningococcal serogroup B, responsible for approximately 60–70% of laboratory-confirmed meningococcal disease cases in the UK, according to NHS England vaccination guidance. Young adults transitioning to university environments face elevated risk due to increased exposure to respiratory droplets in shared accommodation. The vaccine’s inclusion in this expanded access initiative reflects both epidemiological evidence and the strategic goal of protecting a high-incidence population before they enter congregate settings.
System-wide implications for immunisation delivery
The pharmacy-led MenB programme represents a broader shift in NHS immunisation strategy toward decentralised, community-based delivery. Health policy expansion of pharmacist prescribing and vaccine administration roles has already demonstrated success with COVID-19 and influenza programmes. This MenB initiative extends that model to a critical adolescent cohort and may serve as a template for other age-targeted vaccination programmes seeking to improve coverage and reduce health inequalities. For further context on vaccination policy and clinical updates, see our clinical updates section.
What this means
Frequently asked questions
Is MenB vaccination free on the NHS?
Yes, the MenB vaccine is provided free of charge for eligible 17 and 18-year-olds through the NHS vaccination programme. Appointments can be booked at participating high street pharmacies across England at no cost to the patient.
Why is MenB vaccination important for university students specifically?
University environments involve shared accommodation and congregate dining, which increase respiratory droplet transmission. Meningococcal serogroup B is responsible for the majority of bacterial meningitis cases in the UK, making vaccination particularly important before entering high-risk settings.
Can I get the MenB vaccine if I am older than 18 or have already started university?
The current catch-up programme targets 17 and 18-year-olds. Older individuals or those with specific risk factors should contact their GP to discuss whether MenB vaccination is appropriate. Some groups at higher risk may be eligible for vaccination outside the routine programme.
The NHS’s expansion of MenB vaccination access through community pharmacies represents a significant step toward equitable immunisation coverage for a vulnerable population cohort. As university term approaches, students and families are encouraged to book appointments promptly to ensure protection is in place before arrival on campus. Further information on vaccine eligibility and pharmacy locations is available through the NHS England website.
Source: NHS England – Young people urged to book lifesaving meningitis jab at high street pharmacies
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage




Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.







